Zeba Khan is vice president of corporate responsibility for Celgene Corporation. She has direct responsibility for managing Celgene’s global health capacity building and access initiatives. She serves as the Corporate Affairs lead for the Inflammation & Immunology Franchise and is a member of the Corporate Affairs Leadership Team. Zeba established the Global Pricing and Market Access function at Celgene and led the development and implementation of pricing, health economics, outcomes research, and market access strategies. Dr Khan also serves on the ISPOR board of directors as Treasurer and is the ISPOR Student Network Faculty Advisor.